The “Wegven” brand Slimming syringe is sold in the Achak pharmacy in Mitte. The “Wegven” shotgun has been available in Germany for a year.
Jens Kalaene | Image Allianz | Getty pictures
CVS health On Thursday, it declared access to the Blockbuster -Weight Loss -Medicament Wegovy for patients who are covered by his Pharmacy Benefit Manager Caremark considerably.
From July 1st, Caremark Wegovy in his forms or lists with covered drugs and makes it the preferred GLP 1 drug against obesity. The move is part of a new partnership between Caremark and Wegovy's manufacturer. Novo NordiskAccording to the CVS publication in the first quarter.
Caremark will also drop the weight loss medication Zepbound from its standard forms at this point in one fell swoop. Eli LillyA CVS spokesman told CNBC. They said these standard forms were the most common under Caremark's customer base and represent tens of millions of patients.
Appropriate patients who are covered by Caremark who are currently taking Zepbound can switch to Wegovy, said the spokesman.
Novo Nordisk's shares closed 1% lower on Thursday, while Eli Lilly's share was more than 11% lower.
It happens that Novo Nordisk is working to increase access to Wegovy, since it is no longer able to achieve even more patients in the country's partnership in the country's partnership in the USA, one of Caremark, one of the largest action managers in the country.
Caremark reduces medication with manufacturers on behalf of insurance plans and creates lists of medication or form that are covered by insurance and reimburses pharmacies for recipes.
Caremark will make the medication available to its members at a “cheaper price”. The PBM negotiated a lower net price for Wegovy about Zepbound for its standard forms and offers customers who choose these plans, said the CVS spokesman.
Caremark's customers who are employers and unions, “determine how much of these savings at Wegovy is divided either through lower premiums or lower copays at the pharmacy switch with its members,” said the spokesman.
Regardless of this, every patient who does not have insurance cover for output or another GLP-1 can still buy Novo Nordisks medication for $ 499 from one of CVS's 9,000 pharmacies, the speaker added.
In his earnings publication, CVS said that it is the first retail pharmacy that is merged with the new online pharmacy of Novo Nordisk, Novocare, to issue patients with recipes on patients with recipes. Novocare offers Wegovy paid for this cheaper price for patients with cash who may have difficulty taking over the list price of around $ 1,000 in front of the insurance and other discounts.
Caremark also combines Wegovy with additional lifestyle support, such as B. personalized nutritional plans, as part of the CVS weight management program.
The announcement is made when the Danish drugmaker runs to record more patients, since many compounding pharmacies are legally held from making cheaper, non -approved versions of Wegovy with rare exceptions.
“At this point, it is not known how migration from the composed pharmacies will take place in other pharmacy settings,” said Prem Shah, President of the CVS Health Group, on Thursday. “But we expect that there will obviously be a certain benefit by opening 9,000 shops, or 9,000 options for patients to get the medication.”
Dave Moore, Executive Vice President of the US operations of Novo Nordisk, said on Thursday in a separate publication that “it is our responsibility to continue working with others throughout the US health system in order to find innovative opportunities to meet the needs of these patients and with authentic, approved, approved, extensive and vulnerable and aggravated to combine affordable way. “
Comments are closed.